Pro-life leaders weigh in on Sebelius’ Plan B call
WASHINGTON, December 9, 2011 (LifeSiteNews.com) – In the days after Health Secretary Kathleen Sebelius put the kibosh on the FDA’s plans to give minors over-the-counter access to the morning-after pill, numerous speculations have arisen as to how one of the most pro-abortion politicians in the United States – as well as Barack Obama himself – found themselves at odds with the nation’s top abortion lobbies.
The FDA on Wednesday responded to a request from the drug’s manufacturer, Teva Pharmaceutical Industries, to consider eliminating the need for a prescription.
But in announcing the final decision, FDA Administrator Margaret Hamburg noted that, while Sebelius had struck down the change, Hamburg herself felt the pill should be free for use by “all females of child-bearing potential,” hinting at a a clash at the highest levels of the administration. Sebelius later explained in her own letter that, especially as such a move would expose the powerful drug to girls as young as 11, the lack of data on Plan B’s effects on younger girls prevented her approval.
While claiming no involvement in the actual decision, President Obama agreed that “the reason Kathleen made this decision is that she could not be confident that a 10-year-old or an 11-year-old going to a drugstore should be able – alongside bubble gum or batteries – be able to buy a medication that potentially, if not used properly, could have an adverse effect.”
Abortion advocates such as the Center for Reproductive Rights and NARAL Pro-Choice America were aghast at the news: NARAL president Nancy Keenan complained that “we expected this kind of action from the Bush administration.” The Planned Parenthood Federation of America (PPFA) responded several hours later in a press release that it was “extremely disapointed.” PPFA president Cecile Richards followed up on Thursday with a public letter requesting a meeting with Sebelius, and on Friday with a critical editorial in the Huffington Post.
Follow Joe Miller at Twitter HERE and Facebook HERE.
Read More at lifesitenews.com By Kathleen Gilbert, lifesitenews.com